Brookstone Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Brookstone Capital Management's DXCM Position: Q2 2026 in Review
Brookstone Capital Management increased its DexCom (DXCM) stake by 4.6% in Q2 2026, buying an estimated $15.9K and bringing the position to 5,391 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.
Brookstone Capital Management first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Brookstone Capital Management held 5,391 shares of DexCom worth $363K as of Q2 2026.
- Brookstone Capital Management bought 239 DexCom shares in Q2 2026, an estimated $15.9K.
- DexCom made up ﹤0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #1028 holding.
- Brookstone Capital Management first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.